(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202409 | 202309 | % Var | 202409 | 202309 | % Var | 202403 | 202303 | % Var | |
| Sales | 41062.00 | 36592.30 | 12.21 | 82738.30 | 71548.70 | 15.64 | 146665.00 | 112588.30 | 30.27 |
| Other Income | 326.20 | 256.00 | 27.42 | 717.00 | 533.40 | 34.42 | 1067.30 | 912.60 | 16.95 |
| PBIDT | 11473.70 | 8608.40 | 33.28 | 23852.60 | 15936.00 | 49.68 | 35657.90 | 11739.20 | 203.75 |
| Interest | 175.50 | 153.20 | 14.56 | 311.00 | 315.00 | -1.27 | 563.50 | 984.40 | -42.76 |
| PBDT | 11298.20 | 8455.20 | 33.62 | 23541.60 | 15621.00 | 50.70 | 35094.40 | 10754.80 | 226.31 |
| Depreciation | 1457.70 | 1494.80 | -2.48 | 2871.90 | 2895.30 | -0.81 | 7247.50 | 5483.40 | 32.17 |
| PBT | 9840.50 | 6960.40 | 41.38 | 20669.70 | 12725.70 | 62.42 | 27846.90 | 5271.40 | 428.26 |
| TAX | 1762.90 | 1474.30 | 19.58 | 3700.30 | 2470.00 | 49.81 | 4586.00 | 1019.30 | 349.92 |
| Deferred Tax | 43.40 | 177.70 | -75.58 | 88.90 | 166.20 | -46.51 | -254.50 | 60.40 | -521.36 |
| PAT | 8077.60 | 5486.10 | 47.24 | 16969.40 | 10255.70 | 65.46 | 23260.90 | 4252.10 | 447.04 |
| Equity | 912.30 | 910.50 | 0.20 | 912.30 | 910.50 | 0.20 | 911.40 | 910.00 | 0.15 |
| PBIDTM(%) | 27.94 | 23.53 | 18.78 | 28.83 | 22.27 | 29.44 | 24.31 | 10.43 | 133.18 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1960.00 |
| Dr. Reddys Labs. | 1160.65 |
| Cipla | 1450.00 |
| Lupin | 2376.00 |
| Zydus Lifesciences | 1118.50 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: